We are live on ! Find out more
LAB icon

Standard BioTools

100 hedge funds and large institutions have $941M invested in Standard BioTools in 2013 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 37 increasing their positions, 32 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 12 (+1)

85% more capital invested

Capital invested by funds: $509M → $941M (+$431M)

79% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 14

32% more call options, than puts

Call options by funds: $10.1M | Put options by funds: $7.66M

16% more repeat investments, than reductions

Existing positions increased: 37 | Existing positions reduced: 32

12% more funds holding

Funds holding: 89100 (+11)

Holders
100
Holders Change
+11
Holders Change %
+12.36%
% of All Funds
2.9%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.06%
New
25
Increased
37
Reduced
32
Closed
14
Calls
$10.1M
Puts
$7.66M
Net Calls
+$2.46M
Net Calls Change
+$2.17M
Name Holding Trade Value Shares
Change
Change in
Stake
O
26
OppenheimerFunds
New York
$5.83M +$4.48M +152,149 New
VAM
27
Visium Asset Management
New York
$5.53M -$6.62M -224,698 -61%
RFC
28
Russell Frank Company
Washington
$5.45M +$103K +3,505 +3%
FWIA
29
Fort Washington Investment Advisors
Ohio
$5.28M -$3.71M -126,062 -48%
OM
30
Opaleye Management
Massachusetts
$5.04M +$3.9M +132,500 New
Geode Capital Management
31
Geode Capital Management
Massachusetts
$4.91M +$703K +23,857 +23%
TCIM
32
TIAA CREF Investment Management
New York
$4.14M
Wellington Management Group
33
Wellington Management Group
Massachusetts
$4.02M +$3.09M +104,800 New
Principal Financial Group
34
Principal Financial Group
Iowa
$3.42M +$266K +9,035 +11%
DCM
35
Driehaus Capital Management
Illinois
$3.35M +$2.57M +87,286 New
Renaissance Technologies
36
Renaissance Technologies
New York
$3.1M -$1.62M -55,000 -40%
D.E. Shaw & Co
37
D.E. Shaw & Co
New York
$3.1M +$962K +32,673 +68%
NIP
38
Nicholas Investment Partners
California
$3.06M +$2.36M +79,975 New
WSA
39
Wall Street Associates
California
$2.97M -$128K -4,330 -5%
Two Sigma Advisers
40
Two Sigma Advisers
New York
$2.95M -$542K -18,400 -19%
Charles Schwab
41
Charles Schwab
California
$2.71M +$194K +6,594 +10%
BIM
42
BlackRock Investment Management
Delaware
$2.67M -$63.7K -2,162 -3%
1832 Asset Management
43
1832 Asset Management
Ontario, Canada
$2.29M +$1.29M +43,782 +277%
FLAM
44
First Light Asset Management
Minnesota
$2.23M +$1.71M +58,175 New
Ohio Public Employees Retirement System (OPERS)
45
Ohio Public Employees Retirement System (OPERS)
Ohio
$2.17M
PAM
46
Panagora Asset Management
Massachusetts
$1.99M +$971K +32,964 +174%
CS
47
Credit Suisse
Switzerland
$1.88M +$1.02M +34,604 +238%
Goldman Sachs
48
Goldman Sachs
New York
$1.81M +$436K +14,791 +46%
California State Teachers Retirement System (CalSTRS)
49
California State Teachers Retirement System (CalSTRS)
California
$1.76M +$8.84K +300 +0.7%
AllianceBernstein
50
AllianceBernstein
Tennessee
$1.71M +$121K +4,100 +10%

LAB Hedge Fund Activity: Q4 2013 in Review

100 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in Standard BioTools (LAB) for Q4 2013, worth a combined $941M — up 85% from $509M a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new LAB positions and 14 closed out — a net gain of 11 holders — while 37 added to existing stakes and 32 trimmed.

The largest buyer was Lord, Abbett & Co, adding an estimated $22M. The largest seller was Jennison Associates, cutting an estimated $20M.

  • 100 institutional investors held Standard BioTools (LAB) as of Q4 2013, up from 89 in Q3 2013.
  • Funds reported $941M of Standard BioTools stock for Q4 2013, up 85% quarter-over-quarter.
  • 25 funds opened new Standard BioTools positions in Q4 2013 and 14 closed out, a net change of +11 holders.
  • The largest Standard BioTools buyer in Q4 2013 was Lord, Abbett & Co, an estimated $22M added.
  • The largest Standard BioTools seller in Q4 2013 was Jennison Associates, an estimated $20M sold.

Based on aggregated 13F filings for Q4 2013.